Antitumor activity of theophylline in combination with paclitaxel: A preclinical study on melanoma experimental lung metastasis

Cancer Biotherapy and Radiopharmaceuticals

Volumn 25, Issue 4, 2010, Pages 497-503

  Lentini, Alessandro ^a   Tabolacci, Claudio ^a   Mattioli, Palma ^a   Provenzano, Bruno ^a   Beninati, Simone ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

B16 F10; melanoma; metastasis; paclitaxel; theophylline

Indexed keywords

PACLITAXEL; THEOPHYLLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; LUNG METASTASIS; MALE; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE SECTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; LUNG NEOPLASMS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PACLITAXEL; THEOPHYLLINE; VASODILATOR AGENTS;

EID: 77956161608     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2010.0787     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225.
2. Higuchi K, Shimizu Y, Yasumura T, et al. Preventive effect of liver carcinogenesis by Juzen-Taiho-To in the patients with liver cirrhosis. Liver Gall Bladder Pancreas 2002;44:341.
3. Sasaki K, Takasaka H, Hirata K. Suppressive effect of Kampo Japanese Herbal Medicine on hepatic tumor metastasis. Jpn J Cancer Clin 2002;48:171.
4. Boehm K, Borrelli F, Ernst E, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev 2009;3:CD005004.
5. Banner KH, Page CP. Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma. Eur Respir J 1995;8:996.
6. Rabe KF, Dent G. Theophylline and airway inflammation. Clin Exp Allergy 1998;28:35.
7. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143.
8. Bergstrand H. Phosphodiesterase inhibition and theophylline. Eur J Respir Dis Suppl 1980;61:37.
9. Fredholm BB. Theophylline actions on adenosine receptors. Eur J Respir Dis Suppl 1980;109:29.
10. Beninati S, Abbruzzese A, Cardinali M. Differences in the post-translational modification of proteins by polyamines between weakly and highly metastatic B16 melanoma cells. Int J Cancer 1993;53:792.
11. Makower D, Malik U, Novik Y, et al. Therapeutic efficacy of theophylline in chronic lymphocytic leukemia. Med Oncol 1999;16:69.
12. Lentini A, Vidal-Vanaclocha F, Facchiano F, et al. Theophylline administration markedly reduces hepatic and pulmonary implantation of B16-F10 melanoma cells in mice. Melanoma Res 2000;10:435.
13. Rogozin EA, Lee KW, Kang NJ, et al. Effects of caffeine analogues on neoplastic transformation: Structure-activity relationship. Carcinogenesis 2008;29:1228.
14. Ryningen A, Stapnes C, Lassalle P, et al. A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid. Leuk Res 2009;33:779.
15. Yoon JK, Park BN, Paik JY, et al. Effects of theophylline on radioiodide uptake in MCF-7 breast cancer and Nis genetransduced Snu-C5 colon cancer cells. Cancer Biother Radiopharm 2009;24:201.
16. Lau DH, Xue L, Young LJ, et al. Paclitaxel (Taxol): An inhibitor of angiogenesis in a highly vascularized transgenic breast cancer. Cancer Biother Radiopharm 1999;14:31.
17. Wani MC, Taylor HL, Wall ME. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 1971;93:2325.
18. Schiff PB, Fant J, Horbitz SB. Promotion of microtubule assembly in vivo by taxol. Nature 1979;277:665.
19. Crossin KL, Carney DH. Microtubule stabilization by taxol inhibits initiation of DNA synthesis by thrombin and by epidermal growth factor. Cell 1981;27:341.
20. Poruchynsky MS, Wang EE, Rudin CM. Bcl-xl is phosphorylated in malignant cells following microtubule disruption. Cancer Res 1998;58:3331.
21. Dumontet C, Sikic BI. Mechanism of action of and resistance to antitubulin agents: Microtubule dynamics, drug transport and cell death. J Clin Oncol 1999;17:1061.
22. Derycke L, Van Marck V, Depypere H, et al. Molecular targets of growth, differentiation, tissue integrity, and ectopic cell death in cancer cells. Cancer Biother Radiopharm 2005;20: 579.
23. Jimenez JJ, Yunis AA. Tumor cell rejection through terminal cell differentiation. Science 1987;238:1278.
24. Thiele CJ, Gore S, Collins S, et al. Differentiate or die: Tie view from Montreal. Cell Death Differ 2000;7:1014.
25. Lentini A, Forni C, Provenzano B, et al. Enhancement of transglutaminase activity and polyamine depletion in B16-F10 melanoma cells by flavonoids naringenin and hesperitin correlate to reduction of the in vivo metastatic potential. Amino Acids 2007;32:95.
26. Leszczyniecka M, Roberts T, Dent P, et al. Differentiation therapy of human cancer: Basic science and clinical applications. Pharm Ther 2001;90:105.
27. Workman P, Twentyman P, Balkwill F, et al. United Kingdom Coordinating Committee on Cancer Research. Guidelines for the welfare of animals in experimental neoplasia. Br J Cancer 1998;77:1-10.
28. Edholm LE. Specific methods for theophylline assay in biological samples. Eur J Respir Dis Suppl 1980;61:45.
29. Lentini A, Autuori F, Mattioli P, et al. Evaluation of the efficacy of potential antineoplastic drugs on tumor metastasis by a computer-assisted image analysis. Eur J Cancer 2000;36: 1572.
30. Balasubramanian S, Eckert RL. Keratinocyte proliferation, differentiation and apoptosis-differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol Appl Pharm 2007;224:214.
31. Sánchez Y, Amrán D, de Blas E, et al. Regulation of genisteininduced differentiation in human acute myeloid leukaemia cells (HL60, NB4). Protein kinase modulation and reactive oxygen species generation. Biochem Pharmacol 2009;77:384.
32. Satoh H, Ishikawa H, Fujimoto M, et al. Combined effects of TNP-470 and paclitaxel in human non-small cell lung cancer cell lines. Anticancer Res 1998;18:1027.
33. Shishido T, Yasoshima T, Denno R, et al. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor NP-470 in combination with cisplatin. Jpn J Cancer Res 1998;89:963.
34. Hu L, Hofmann J, Zaloudek C, et al. Vascular endothelial growth factor immunoneutralization plus paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer. Am J Pathol 2002;161:1917.
35. Recchia F, Sica G, De Filippis S, et al. Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer. Anticancer Res 1997;17: 3761.
36. Montopoli M, Ragazzi E, Froldi G, et al. Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells. Cell Prolif 2009;42:195.
37. Benoehr P, Krueth P, Bokemeyer C, et al. Nephroprotection by theophylline in patients with cisplatin chemotherapy: A randomized, single-blinded, placebo-controlled trial. J Am Soc Nephrol 2005;16:452.
38. Li X, Choi JS. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats. Int J Pharm 2007;337:188.
39. George S, Kasimis BS, Cogswell J, et al. Phase I study of flavopiridol in combination with Paclitaxel and Carboplatin in patients with non-small-cell lung cancer. Clin Lung Cancer 2008;9:160.
40. Lentini A, Provenzano B, Tabolacci C, et al. Proteinpolyamine conjugates by transglutaminase 2 as potential markers for antineoplastic screening of natural compounds. Amino Acids 2009;36:701.